Physician

Charles Darragh, MD

According to 2025 Medicare claims, Charles Darragh, MD (NPI: 1245676774) practices micrographic dermatologic surgery in the Greenville-Anderson-Greer, SC market, with the plurality of this provider's patient population coming from Greenville, SC. This provider's primary affiliated billing organization is CAROLINA DERMATOLOGY PA (NPI: 1104678085; TIN: 992276464) and primary practice location at 29607-4105. Darragh is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Darragh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 868 traditional Medicare patients, billed 4,420 HCPCS/CPT codes, and received $739,031 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 652 prescription claims across 381 beneficiaries totaling $7,254 in drug costs, led by Mupirocin (Mupirocin). Open Payments data shows 14 records totaling $420. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $13,351 to $7,254. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	225	993	$160,847
2019	685	3,495	$567,737
2020	740	4,212	$656,406
2021	787	4,671	$696,266
2022	759	3,920	$615,162
2023	808	3,751	$598,005
2024	868	4,420	$739,031

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	52	157	$13,351
2016	88	290	$154,169
2017	73	182	$63,539
2018	122	192	$4,713
2019	267	514	$15,024
2020	291	582	$10,962
2021	328	653	$14,183
2022	310	597	$12,412
2023	273	480	$10,820
2024	381	652	$7,254

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	562	707	$419
17312	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks	257	355	$299
13132	Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm	228	238	$182
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	230	316	$58
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	255	313	$39

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mupirocin	Mupirocin	225	5,412	$1,360
Clobetasol Propionate	Clobetasol Propionate	18	610	$1,225
Doxycycline Hyclate	Doxycycline Hyclate	119	1,234	$1,083
Ketoconazole	Ketoconazole	62	1,634	$699
Betamethasone Dipropionate	Betamethasone Dipropionate	17	560	$545

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	14	$420	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charles Darragh, MD?

Tedicare shows public-source Medicare data for Charles Darragh, MD (NPI 1245676774), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles Darragh, MD have ACO affiliation data?

Charles Darragh, MD is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Charles Darragh, MD?

Charles Darragh, MD is linked to CAROLINA DERMATOLOGY PA (billing NPI 1104678085) in the available physician profile data.

Does Charles Darragh, MD have Open Payments data?

Charles Darragh, MD has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.